Skip to main content
. Author manuscript; available in PMC: 2019 May 6.
Published in final edited form as: J Subst Abuse Treat. 2016 Nov 11;73:27–34. doi: 10.1016/j.jsat.2016.11.001

Table 3:

Odds of initiation of and engagement with addictions treatment for black and Hispanic, relative to white, VA patients with alcohol use disorders.

Total N Black Hispanic

OR [95% CI] OR [95% CI]

INITIATION AND ENGAGEMENT WITH SPECIALTY ADDICTIONS TREATMENT

Initiation of Specialty Addictions Care* 302,406 79,585 21,476

Unadjusted 1.80 (1.77, 1.84) 1.41 (1.36, 1.46)
Adjusted for facility-level characteristics 1.80 (1.77, 1.84) 1.41 (1.36, 1.46)
Adjusted for facility and predisposing 1.75 (1.71, 1.78) 1.25 (1.20, 1.29)
Adjusted for facility, predisposing, and enabling 1.70 (1.67, 1.74) 1.26 (1.22, 1.31)
Adjusted for facility, predisposing, enabling, and need 1.38 (1.35, 1.41) 1.21 (1.16, 1.25)

Engagement with Specialty Addictions Treatment (Among all Patients) 302,406 79,585 21,476

≥ 3 visits within 1st month*
Unadjusted 1.85 (1.81, 1.89) 1.34 (1.29, 1.39)
Adjusted for facility-level characteristics 1.85 (1.82, 1.89) 1.34 (1.29, 1.39)
Adjusted for facility and predisposing 1.77 (1.73, 1.81) 1.21(1.17, 1.26)
Adjusted for facility, predisposing, and enabling 1.72 (1.68, 1.75) 1.23 (1.18, 1.28)
Adjusted for facility, predisposing, enabling, and need 1.36 (1.33, 1.40) 1.17 (1.12, 1.21)

≥2 visits in each of the 1st 3 months (6 total visits in 3 months)*
Unadjusted 1.94 (1.89, 1.98) 1.28 (1.22, 1.34)
Adjusted for facility-level characteristics 1.94 (1.90, 1.99) 1.28 (1.23, 1.34)
Adjusted for facility and predisposing 1.82 (1.78, 1.86) 1.19 (1.14, 1.25)
Adjusted for facility, predisposing, and enabling 1.76 (1.72, 1.80) 1.20 (1.15, 1.26)
Adjusted for facility, predisposing, enabling, and need 1.39 (1.36, 1.43) 1.13 (1.08, 1.19)

Engagement With Specialty Addictions Treatment (Among only Patients who Initiated Specialty Treatment) 90,789 30,303 6,816

≥ 3 visits in 1st month **
Unadjusted 1.33 (1.28, 1.38) 0.93 (0.87, 0.99)
Adjusted for facility-level characteristics 1.33 (1.28, 1.39) 0.93 (0.87, 0.99)
Adjusted for facility and predisposing 1.25 (1.20, 1.30) 0.96 (0.90, 1.03)
Adjusted for facility, predisposing, and enabling 1.23 (1.19, 1.29) 0.97 (0.91, 1.04)
Adjusted for facility, predisposing, enabling, and need 1.09 (1.05, 1.14) 0.95 (0.89, 1.02)

≥2 visits in the 1st 3 months of treatment (6 total visits in 3 months)**
Unadjusted 1.38 (1.33, 1.42) 0.93 (0.88, 0.99)
Adjusted for facility-level characteristics 1.38 (1.34, 1.43) 0.94 (0.88, 0.99)
Adjusted for facility and predisposing 1.29 (1.25, 1.33) 0.97 (0.92, 1.03)
Adjusted for facility, predisposing, and enabling 1.27 (1.22, 1.31) 0.98 (0.92, 1.04)
Adjusted for facility, predisposing, enabling, and need 1.16 (1.12, 1.20) 0.95 (0.90, 1.01)

HEDIS INITIATION AND ENGAGEMENT WITH SPECIALTY TREATMENT OR AUD CARE IN GENERAL HOSPITAL SETTING

HEDIS Initiation (access in first 14 days after index visit)* 302,406 79,585 21,476

Unadjusted 1.38 (1.34, 1.41) 1.10 (1.06, 1.15)
Adjusted for facility-level characteristics 1.38 (1.34, 1.41) 1.11 (1.06, 1.16)
Adjusted for facility and predisposing 1.34 (1.31, 1.37) 1.03 (0.99, 1.08)
Adjusted for facility, predisposing, and enabling 1.30 (1.27, 1.33) 1.05 (1.00, 1.09)
Adjusted for facility, predisposing, enabling, and need 1.10 (1.07, 1.12) 0.98 (0.94, 1.02)

HEDIS Engagement (Among all Patients)* 302,406 79,585 21,476

Unadjusted 1.46 (1.41, 1.52) 1.13 (1.05, 1.22)
Adjusted for facility-level characteristics 1.47 (1.41, 1.53) 1.14 (1.06, 1.24)
Adjusted for facility and predisposing 1.40 (1.35, 1.46) 1.03 (0.95, 1.12)
Adjusted for facility, predisposing, and enabling 1.36 (1.31, 1.42) 1.05 (0.97, 1.14)
Adjusted for facility, predisposing, enabling, and need 1.14 (1.09, 1.19) 1.00 (0.92, 1.08)

HEDIS Engagement (Among those who met criteria for HEDIS initiation)*** 52,666 16,501 3, 649

Unadjusted 1.15 (1.10, 1.21) 1.03 (0.94, 1.13)
Adjusted for facility-level characteristics 1.16 (1.10, 1.21) 1.04 (0.95, 1.14)
Adjusted for facility and predisposing 1.14 (1.09, 1.20) 1.00 (0.91, 1.09)
Adjusted for facility, predisposing, and enabling 1.14 (1.09, 1.20) 1.01 (0.93, 1.11)
Adjusted for facility, predisposing, enabling, and need 1.08 (1.03, 1.13) 1.00 (0.92, 1.10)

Relative to white patients

*

(n=201345)

**

(n=53760)

***

(n=32516)

Bolded results indicate significance at a p < 0.05 level